Richard A. Heyman
Director · Oric Pharmaceuticals, Inc.
IndividualSelling only22 10b5-1 trades
- 2024
- Oct 2, 2026
- 13
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Richard A. Heyman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Dominic Piscitelli - $1.95M in ORIC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Richard A. Heyman?
Richard A. Heyman is a corporate insider, tracked as Director of Oric Pharmaceuticals, Inc. (ORIC). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Richard A. Heyman submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Richard A. Heyman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 18 open-market sales ($916K) across all tracked filings.
